Novel Combination Therapy Shows Superior Weight Loss in Adults with Obesity

Obesity is a complex, chronic disease associated with numerous comorbidities like type 2 diabetes, cardiovascular disease, and certain cancers. While existing pharmacotherapies like GLP-1 receptor agonists have shown significant efficacy, many individuals still struggle to achieve substantial and sustained weight loss. This study addresses the critical need for more effective and comprehensive pharmacological interventions to achieve greater weight reduction in adults with overweight or obesity.